DTC
RPTX

Deep Track Capital’s Repare Therapeutics RPTX Stock Holding History

Deep Track Capital’s Portfolio RPTX Stock Details RPTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-904,261
Closed -$2.98M – 79
2024
Q2 		$2.98M Sell
904,261
-1,780,083
-66% -$6.35M 0.09% 63
2024
Q1 		$12.6M Sell
2,684,344
-308,387
-10% -$1.98M 0.36% 49
2023
Q4 		$21.8M Sell
2,992,731
-75,000
-2% -$420K 0.77% 46
2023
Q3 		$37.1M Buy
3,067,731
+340,125
+12% +$3.51M 1.44% 24
2023
Q2 		$28.9M Hold
2,727,606
– – 1.35% 23
2023
Q1 		$26.8M Hold
2,727,606
– – 1.14% 31
2022
Q4 		$40.1M Sell
2,727,606
-400,061
-13% -$5.98M 1.75% 23
2022
Q3 		$37.9M Buy
3,127,667
+420,005
+16% +$5.41M 1.87% 19
2022
Q2 		$37.9M Buy
2,707,662
+43,645
+2% +$514K 2.62% 16
2022
Q1 		$37.9M Buy
2,664,017
+564,017
+27% +$8.36M 2.45% 15
2021
Q4 		$44.3M Buy
+2,100,000
New +$49.5M 3.27% 9

Other funds holding RPTX

BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
BOCH
Blue Owl Capital Holdings New York $369M AUM 78.25% 1-Year Est. Return
O
OrbiMed New York $4.59B AUM 125.28% 1-Year Est. Return
VVM
Versant Venture Management San Francisco, California $141M AUM 190.82% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
MAM
MPM Asset Management Boston, Massachusetts $44.5M AUM 47.28% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
MB
MPM BioImpact Boston, Massachusetts $1.29B AUM 141.72% 1-Year Est. Return
ACM
Aquilo Capital Management San Francisco, California $37.1M AUM 41.76% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return